Unlock Industry Perspectives on the Advantages and Challenges of Developing Advanced Dosage Forms
Summary: What advantages are there for drug developers to choose advanced dosage forms for new molecules in their development pipelines? Or, are advanced dosage forms more suitable for expanding companies’ product portfolios with the existing molecules? How can innovators select the dosage forms and technologies that are the most suitable for oral delivery? To answer these questions, FiercePharma and Catalent conducted a survey to understand the factors affecting innovators’ decision to choose a particular dosage form. In this webinar, industry experts present the survey results and share insights on how advanced dosage forms can address the specific attributes of a molecule, and patients’ needs.
Watch the webinar to learn about the tools and technologies for creating dosage forms such as orally disintegrating tablets (ODTs), multi-particulates, and modified release formulations.